Role of the surgeon as a variable in the treatment of rectal cancer

Seminars in Surgical Oncology

Volumn 19, Issue 4, 2000, Pages 329-335

  Hermanek, Paul ^a   Hermanek, Peter J ^b,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Bavarian Permanent Working Party for Quality Assurance (BAQ)   (Germany)

^c NONE   (Germany)

Author keywords

Clinical trials; Colorectal surgery; Health care; Quality assurance; Rectal neoplasms

Indexed keywords

CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HEALTH CARE; HUMAN; LYMPHADENECTOMY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUALITY CONTROL; RECTUM CANCER; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE;

COLORECTAL SURGERY; HUMANS; RECTAL NEOPLASMS; RECTUM;

EID: 0034474188     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.3     Document Type: Review

References (38)

1. Colorectal cancer
2. Prognostic factor research in oncology
3. Prognostic factors of rectum carcinoma - Experience of the German multicentre study SGCRC
4. Outcomes in rectal cancer surgery are directly related to technical factors
5. Ist der chirurg ein prognostisch relevanter faktor nach R0-resection colorectaler carcinome?
6. Prognostische Faktoren der lokalrezidivrate nach operativer therapie von rektumkarzinomen
7. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy
8. Surgeon-related factors and outcome in rectal cancer
9. Factors affecting survival after excision of the rectum for cancer
10. Which surgeons in a district general hospital should treat patients with carcinoma of the rectum?
11. Outcome in patients with colorectal cancer managed by surgical trainees
12. Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: A population-based study in the West Netherlands
13. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients
14. Die operations-methodik bestimmt die rezidivhäufigkeit colorectaler carcinome
15. The German experience. The surgeon as a prognostic factor in colon and rectal cancer surgery
16. Variations in treatment of rectal cancer
17. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer
18. Untersuchungen zum einfluß der regional zentralisierten behandlung auf die überlebenschancen beim rektumkarzinom in der DDR
19. Survival after rectal cancer: Differences between hospital catchment areas. A nationwide study in Sweden
20. The mesorectum in rectal cancer surgery: Clue to pelvic recurrence
21. Total mesorectal excision and local recurrence: A study of tumour spread in the mesorectum distal to rectal cancer
22. Pathological evidence in support of total mesorectal excision in the management of rectal cancer
23. Regional mesenteric recurrence of colorectal cancer after anterior resection or left hemicolectomy: Inadequate primary resection demonstrated by angiography of the remaining arterial supply
24. Intraoperative spillage of tumor cells in surgery for rectal cancer
25. International standardization and documentation of the treatment of rectal cancer
26. What can the pathologist tell the surgeon about rectal cancer resection
27. The pathologist, the surgeon and colorectal cancer - Get it right because it matters
28. Verfahren zur postoperativen kontrolle der vollständigen exzision des mesorektums: Interne qualitätssicherung in der tumorchirurgie
29. Mesorectal excision for rectal cancer
30. Total mesorectal excision in the operative treatment of carcinoma of the rectum
31. Analysis of locoregional recurrence rates after surgery alone for rectal cancer
32. Total mesorectal excision: Evaluating the evidence
33. Mesorectal excision for rectal cancer
34. Total mesorectal excision in the treatment of rectal cancer: A view from the USA
35. Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997
36. Is radiochemotherapy necessary in the treatment of rectal cancer?
37. Surgical treatment of adenocarcinoma of the rectum
38. Quality of cancer surgery. Challenges and controversies